<DOC>
	<DOCNO>NCT02665585</DOCNO>
	<brief_summary>The aim present positive-control study analyze compare rate off-table subclinical neurological event two group patient submit carotid artery stenting ( CAS ) two different kind stent , close-cell stent , new mesh-covered stent , verify new model stent effective prevent postprocedural carotid plaque embolism .</brief_summary>
	<brief_title>Plaque Prolapse Prevention Carotid Artery Stenting ( 3PCAS )</brief_title>
	<detailed_description>Scientific background explanation rationale : CAS select asymptomatic patient proven effective reduce risk carotid-related neurological ischemic event select patient . It also carry not-negligible risk intraprocedural postprocedural ( so-called `` off-table '' ) embolic event cause clinical ( TIA , stroke , death ) subclinical ( Magnetic Resonance Imaging - MRI-detectable microembolic brain lesion , cognitive impairment , increase marker brain injury ) morbidity . CAS technique progressively refine order minimize risk intraprocedural embolism , despite increase use close-cell design stent risk plaque prolapse stent strut postprocedural embolism still exist . In order prevent plaque prolapse new stent design conceive realize . It combine traditional open-cell design exterior PET mesh able capture keep place plaque debris small 150-180µm . The aim present positive-control study analyze compare rate off-table subclinical neurological event two group patient submit CAS two different kind stent , close-cell stent , new mesh-covered stent , verify new model stent effective prevent postprocedural carotid plaque embolism . Methods Trial Design : single-center , superiority , randomize control trial compare result two different carotid stent patient affect asymptomatic ≥70 % carotid artery stenosis . Participants : CAS inclusion criterion : age 55 year , presence carotid stenosis ≥70 % ( NASCET evaluation criterion ) , previous neurologic symptom refer medical history , absence previous brain ischemic lesion detect Diffusion Weighted ( DW ) -MRI . Patients symptomatic carotid lesion , previous ischemic lesion detect DW-MRI , inability give consent exclude study . Exclusion criterion CAS : significant contraindication angiography , history bleed disorder , intracranial aneurysm vascular malformation hemorrhage , presence intraluminal thrombus , poor entry point femoral artery , type 2-3 arch , bovine arch , severe aortic arch ipsilateral ostial common carotid brachiocephalic atherosclerosis , severe proximal common distal internal carotid artery tortuosity , sharply angulate internal carotid artery , carotid string sign , circumferential calcification carotid plaque , length target lesion require one stent . Eligibility criteria randomization : obtain informed consent , compliance study protocol . Patients randomize receive either carotid Wallstent ( Boston Scientific , Marlborough , MA , USA ) C-Guard carotid stent ( Inspire-MD , Tel-Aviv , Israel ) new mesh-covered open-cell stent . Written inform consent obtain enrollment . Setting : data collect analyzed Vascular Unit Academic Centre . Interventions : CAS intervention perform distal embolic protection device case ( Filterwire , Boston Scientific , Marlborough , MA , USA ) . Wallstent C-Guard stent alternatively use cover whole plaque surface . DW-MRI performance : patient submit preoperative , immediate postoperative , 72 hour postoperatively DW-MRI . The comparison immediate postoperative 72-hour examination detect off-table event . Presence recent ischemic lesion preoperative examination consider exclusion criterion enter study . MiniMentalStateExamination ( MMSE ) Test MontrealCognitive Assessment ( MOCA ) Test administration interpretation : patient submit preoperative 72-hour postoperative MMSE MOCA test order prove effect CAS-related microemboli cognitive performance . The research assistant responsible performing test preoperatively postoperatively patient train administer score test . Downgrading postoperative examination , normal cognitive impairment ( 1 step ) difference ≥4 postoperative score compare preoperative value consider significant . No psychotropic sedative medication administer patient perform test . NeuroSpecificEnolase ( NSE ) S100β serum level detection analysis : The S100 test measure β-subunit protein S100 define three monoclonal antibody detection limit 0.02 µg/L . NSE measurement base monoclonal antibody bind γ-subunit enzyme minimal measurable concentration 0.3 µg/L . S100β NSE proteins analyze use automate immunoluminometric assay ( S100 Elecsys test , Roche Diagnostics GmbH , Mannheim , Germany ; ELSA-NSE , CIS Bio International , Gif-sur-Yvette Cedex , France ) . Venous blood sample obtain patient preoperatively ( basal sample ) , 5 minute embolic protection device retrieval , 2 , 12 , 24 , 48 hour end procedure . Samples allow clot . After centrifugation ( 1800g 6 minute ) ≤20 minute collection , serum store -80°C later analysis . Objective : demonstrate decrease off-table microembolic event rate patient submit CAS C-Guard stent implantation compare patient Wallstent implantation , detect DW-MRI , marker brain injury , neuropsychometric test . Sample size estimation : assume type I error α=0.05 , type II error β=0.20 , power ( 1-β ) =0.80 , event rate control ( Wallstent ) group 0.40 ( 40 % ) , event rate treatment ( C-Guard ) group 0.10 ( 10 % ) , assume 30 % event rate reduction treatment group , estimation sample size treatment group 29 . Randomisation : computer-generated random allocation sequence would use . A blocked randomization perform allocation ratio 1:1 . Allocation concealment use . Blind postprocedural DW-MRI assessment/interpretation , neurobiomarkers level evaluation , MMSE MOCA administration do assess outcome .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<criteria>presence carotid stenosis ≥70 % ( NASCET evaluation criterion ) previous neurologic symptom refer medical history absence previous brain ischemic lesion detect DWMRI symptomatic carotid lesion previous ischemic brain lesion detect DWMRI inability give consent Exclusion criterion CAS : significant contraindication angiography , history bleed disorder , intracranial aneurysm vascular malformation hemorrhage , presence intraluminal thrombus , poor entry point femoral artery , type 23 arch , bovine arch , severe aortic arch ipsilateral ostial common carotid brachiocephalic atherosclerosis , severe proximal common distal internal carotid artery tortuosity , sharply angulate internal carotid artery , carotid string sign , circumferential calcification carotid plaque , length target lesion require one stent</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>carotid disease</keyword>
	<keyword>stroke</keyword>
	<keyword>stent</keyword>
	<keyword>carotid stenting</keyword>
</DOC>